Safety, Tolerability, and Activity of ISIS 113715 in People With Type 2 Diabetes Mellitus Who Have Not Received Prior Treatment

NCT00330330 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
96
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Ionis Pharmaceuticals, Inc.